Analysts Opinions on: Johnson & Johnson (NYSE:JNJ)


Johnson & Johnson (NYSE:JNJ) currently has a “Sell” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Buy” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.

Johnson & Johnson (NYSE:JNJ) gained 1.3 Percent and closed its previous trading session at $134.35. The stock traded with the average Volume of 7.81 Million at the end of last session.

Johnson & Johnson (NYSE:JNJ) has the Market Capitalization of 368.39 Billion. The Stock has its 52-week High of $148.32 and 52-Week Low of $120.95 and it touched its 52-week high on 01/17/18 and 52-Week Low on 04/18/17.

The company reported its last earnings Actual EPS of $1.74/share. While, the analyst predicted that the company could provide an EPS of $1.72/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.02/share which shows an Earnings Surprise of 1.2 Percent.

Sell side analysts plays vital role in buying and selling a stock where 5 analysts rated Johnson & Johnson (NYSE:JNJ) as Buy, 0 analysts given Outperform signal, 1 reported Hold, and 1 analysts rated the stock as Sell.

The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 2.86% where SMA50 and SMA200 are -1.74% and -0.9% respectively.

The company shows its Return on Assets (ROA) value of 0.9%. The Return on Equity (ROE) value stands at 1.9%. While it’s Return on Investment (ROI) value is 15.7%.

Johnson & Johnson (NYSE:JNJ) currently has a Weekly Volatility of 1.71% percent while its Monthly Volatility is at 1.81% percent. While talking about Performance of the Stock, Johnson & Johnson currently has a Weekly performance of 4.78%, monthly performance percentage is 3.72 percent, Quarterly performance is -4.44 percent, 6 months performance shows a percent value of 0.86% and Yearly Performance is 6.05 percent.

Company Profile:

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women’s health fields, nutritional and over-the-counter pharmaceutical products. The company’s Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women’s health products. Johnson & Johnson is based in New Brunswick, New Jersey.